help button home button Endocrine Society JCEM ENDO 08
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sawka, A. M.
Right arrow Articles by Gerstein, H. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sawka, A. M.
Right arrow Articles by Gerstein, H. G.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 5 2507
Copyright © 2004 by The Endocrine Society


Letter to the Editor

Authors’ Response: Patients on Appropriate T4 Replacement Are as Content as They Would Be on Any Thyroid Hormone

A. M. Sawka and H. G. Gerstein

Division of Endocrinology and Metabolism, McMaster University, Hamilton, Ontario, Canada L8N 1G6

Address correspondence to: Anna M. Sawka, M.D., c/o Lehana Thabane, Center for Evaluation of Medicines, 105 Main Street East, Level P1, Hamilton, Ontario L8N 1G6, Canada.

To the editor:

Dr. Laurberg has suggested that one of the reasons that may explain, in part, the observations of a decreased sense of general well-being in some treated hypothyroid patients may be that there is "bias in diagnosing and therapy" (1). Dr. Laurberg has specifically commented on data suggesting that individuals who are treated with thyroid hormone are more likely to have both a high General Health Questionnaire score and other medical comorbidities, such as diabetes, cardiac disease, stroke, hypertension, epilepsy, and depression (2, 3). We agree with Dr. Laurberg that these data are consistent with the possibility that patients presenting with symptoms of depression, general sense of a lack of well-being, or other medical conditions (which may themselves be associated with decreased quality of life, such as diabetes) may be more likely to be screened for, diagnosed with, and treated for hypothyroidism. Such symptoms may be persistent, despite T4 therapy (particularly if hypothyroidism is not the cause of the impaired well-being), and the depressed quality of life noted in T4-treated patients may be wrongly attributed to T4 therapy itself. Such an explanation may explain, in part, the lack of effect of the addition of T3 to T4 therapy (in patients with a normal TSH) in improving general sense of well-being, as seen in our study (4). If further trials of T3 therapy fail to detect a benefit on well-being, the need to look at nonthyroidal approaches may be more pressing.

Received January 23, 2004.

Accepted January 23, 2004.

References

  1. Laurberg P 2004 Patients on appropriate T4 replacement are as content as they would be on any thyroid hormone. J Clin Endocrinol Metab 89:2507 (Letter)[Free Full Text]
  2. Kaplan MM, Sarne DH, Schneider AB 2003 Editorial: in search of the impossible dream? Thyroid hormone replacement therapy that treats all symptoms in all hypothyroid patients. J Clin Endocrinol Metab 88:4540–4542[Free Full Text]
  3. Saravanan P, Chau F, Roberts V, Vedhara K, Greenwood R, Dayan CM 2002 Psychological well-being in patients on ‘adequate’ doses of L-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf) 57:577–585[CrossRef][Medline]
  4. Sawka AM, Gerstein HC, Marriott MJ, MacQueen GM, Joffe RT 2003 Does a combination regimen of thyroxine (T4) and 3,5,3'-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 88:4551–4555[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sawka, A. M.
Right arrow Articles by Gerstein, H. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sawka, A. M.
Right arrow Articles by Gerstein, H. G.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals